Reverse activity-based protein profiling identifies a class of METTL16 covalent inhibitors. // Cancer Bioscience. – URL: https://www.sciencedirect.com/science/article/pii/S3117467126000016?dgcid=rss_sd_all
Reverse activity-based protein profiling identifies a class of METTL16 covalent inhibitors. Cancer Bioscience. https://www.sciencedirect.com/science/article/pii/S3117467126000016?dgcid=rss_sd_all
“Reverse activity-based protein profiling identifies a class of METTL16 covalent inhibitors.” Cancer Bioscience.
@article{article39390,
title = {Reverse activity-based protein profiling identifies a class of METTL16 covalent inhibitors},
journal = {Cancer Bioscience},
url = {https://www.sciencedirect.com/science/article/pii/S3117467126000016?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez